- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02570568
Pen Torch Transillumination: Shedding Light on Difficult Venepuncture
Our novel technique of pen-torch transillumination (PTI) uses a cheap and easily available instrument (Penlite-LP212®, Energizer®, Missouri, USA) to visualize superficial veins invisible to the naked eye. The investigators evaluate the efficacy of PTI in improving venepuncture success rate (SR) for patients with poor venous access.
This prospective randomized controlled trial looks at adult patients aged 21 to 90 with difficult venous access (history of ≥3 consecutive attempts required for successful cannulation during the current admission) requiring non-emergent venepuncture. Patients will undergo venepuncture over the upper-limb using one of the following: Conventional venepuncture (control); Veinlite® (TransLite®, Texas, USA), a commercial transillumination device; PTI. Outcome measures are: successful cannulation within 2 attempts; duration of each successful attempt. Fisher's exact and Kruskal-Wallis tests will be performed.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a prospective randomized controlled trial. Patients with a history of difficult venepuncture who agree to be entered into the study will be randomized into one of 3 groups using a sealed envelope system: 1. Conventional venepuncture (Control Group, n=25); 2. Veinlite® a commercial LED transilluminator device (Experimental Group 1, n=25); 3. Pen torch transillumination (Experimental Group 2, n=25). Hemodynamically unstable patients are excluded. The nurse involved in the care of the patient will attempt venepuncture over the upper limb. A maximum of 4 times attempts is allowed, before escalation to a doctor/phlebotomist.
A standardized venepuncture technique using standardized instruments will be utilized. Veins will be localized using one of the above techniques. Pen torch transillumination and veinlite are non-invasive techniques for locating veins. For pen torch transillumination, the tip of the pen torch is pressed onto the skin, causing the shadow of the vein to show up. Veinlite uses a device that emits red light. Placing it onto the skin will cause the outlines of the veins to show up. Once a suitable vein is localized, a tourniquet is applied (Braun® International, USA). The area of the skin to be cannulated is disinfected with an alcohol wipe (Webcol®, Covidien®, USA). For the setting of IV cannulation, a standardized 23G IV cannula is used (Introcan Safety®, Braun®, USA). Normal saline (PosiFlush® 3ml, BD®, USA) will be used for flushing the cannula after successful cannulation. For blood taking, a syringe (Terumo®, Philippines) ranging from 2ml to 20ml and a 23G needle (Venofix®, Braun®, USA) will be used. All instruments needed for venepuncture, including 4 IV cannula or 4 needles should be by the patient's bedside prior to the start of each venepuncture.
Duration of the procedure will be recorded using a stop watch. This is defined as the time (in minutes) from the start of attempt to localize a vein to its successful cannulation. Successful cannulation is defined either as the ability to flush 2ml of normal saline into the IV cannula or the ability to draw 2ml of blood from the vein.
A post-procedure questionnaire will be filled up by the nurses after attempt at venepuncture (refer to attached file). Outcome data include: number of attempts and duration needed for successful venepuncture. Patient data include: age, sex, race, body-mass index, history of intra-venous drug abuse, and renal function.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Singapore, Singapore, 119074
- National University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- History of ≥3 consecutive attempts required for successful cannulation during the current admission
- Patients requiring non-emergent venous cannulation for blood sampling or intra-venous plug insertion
Exclusion Criteria:
- Patients who are haemodynamically unstable
Respiratory Rate (< 8 or > 30 / min) SpO2 (< 93% on max 4L O2 on NP) Pulse rate (< 40 or > 130 bpm) Blood pressure (SBP < 90 mmHg) Acute change in mental state
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Conventional Venepuncture
Veins will be identified by a combination of visualization and palpation.
Once a suitable vein is localized, a tourniquet is applied (Braun® International, USA).
The area of the skin to be cannulated is disinfected with an alcohol wipe (Webcol®, Covidien®, USA).
For the setting of IV cannulation, a standardized 23G IV cannula is used (Introcan Safety®, Braun®, USA).
Normal saline (PosiFlush® 3ml, BD®, USA) will be used for flushing the cannula after successful cannulation.
For blood taking, a syringe (Terumo®, Philippines) ranging from 2ml to 20ml and a 23G needle (Venofix®, Braun®, USA) will be used.
All instruments needed for venepuncture, including 4 IV cannula or 4 needles should be by the patient's bedside prior to the start of each venepuncture.
|
This involves the conventional method of identifying veins suitable for venepuncture, which involves visualization and palpation.
|
Experimental: Veinlite
Placing Veinlite onto the skin will cause the outlines of the veins to show up.
Once a suitable vein is localized, a tourniquet is applied (Braun® International, USA).
The area of the skin to be cannulated is disinfected with an alcohol wipe (Webcol®, Covidien®, USA).
For the setting of IV cannulation, a standardized 23G IV cannula is used (Introcan Safety®, Braun®, USA).
Normal saline (PosiFlush® 3ml, BD®, USA) will be used for flushing the cannula after successful cannulation.
For blood taking, a syringe (Terumo®, Philippines) ranging from 2ml to 20ml and a 23G needle (Venofix®, Braun®, USA) will be used.
All instruments needed for venepuncture, including 4 IV cannula or 4 needles should be by the patient's bedside prior to the start of each venepuncture.
|
Veinlite is a device that emits red light.
It provides a non-invasive technique of inserting intra-venous cannula.
Placing it onto the skin will cause the outlines of the veins to show up.
|
Experimental: Pen-torch Transillumination
The tips of the pen torches are pressed onto the skin, causing the silhouette of the vein to show up.
Once a suitable vein is localized, a tourniquet is applied (Braun® International, USA).
The area of the skin to be cannulated is disinfected with an alcohol wipe (Webcol®, Covidien®, USA).
For the setting of IV cannulation, a standardized 23G IV cannula is used (Introcan Safety®, Braun®, USA).
Normal saline (PosiFlush® 3ml, BD®, USA) will be used for flushing the cannula after successful cannulation.
For blood taking, a syringe (Terumo®, Philippines) ranging from 2ml to 20ml and a 23G needle (Venofix®, Braun®, USA) will be used.
All instruments needed for venepuncture, including 4 IV cannula or 4 needles should be by the patient's bedside prior to the start of each venepuncture.
|
Pen-torch Transillumination is a non-invasive technique that utilizes 2 pen-torches to provide illumination.The tips of the pen torches are pressed onto the skin, causing the silhouette of the vein to show up
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of venepuncture attempts
Time Frame: 1 day
|
We record the number of attempts required for successful venepuncture
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Duration of venepuncture
Time Frame: 1 day
|
A stopwatch will be used to measure the duration required from the start of vein identification, to the end of a successful venepuncture attempt.
|
1 day
|
Collaborators and Investigators
Investigators
- Principal Investigator: Thiam Chye Lim, FRCS, National University Hospital, Singapore
Publications and helpful links
General Publications
- Katsogridakis YL, Seshadri R, Sullivan C, Waltzman ML. Veinlite transillumination in the pediatric emergency department: a therapeutic interventional trial. Pediatr Emerg Care. 2008 Feb;24(2):83-8. doi: 10.1097/PEC.0b013e318163db5f.
- Yen K, Gorelick MH. New biomedical devices that use near-infrared technology to assist with phlebotomy and vascular access. Pediatr Emerg Care. 2013 Mar;29(3):383-5; quiz 386-7. doi: 10.1097/PEC.0b013e31828680f9.
- Mbamalu D, Banerjee A. Methods of obtaining peripheral venous access in difficult situations. Postgrad Med J. 1999 Aug;75(886):459-62. doi: 10.1136/pgmj.75.886.459.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2014/00152
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Disorder of Vein
-
Boston Scientific CorporationWithdrawnChronic Venous Disorder | Venous Outflow Obstruction | Systemic Vein Outflow of Iliofemoral Vein
-
Boston Scientific CorporationCompletedChronic Venous Disorder | Venous Outflow Obstruction | Symptomatic Venous Outflow Obstruction of Iliofemoral VeinUnited States, Ireland, United Kingdom, Netherlands, France, Germany, Spain
-
Ankara UniversityUnknownValue of Central Landmark Method for Juguler Vein CatheterizationTurkey
-
New York Institute of TechnologyTerminatedSedentary Behavior | Compression; Vein | Compression; Artery | DVT of LegsUnited States
-
Shanghai Ninth People's Hospital Affiliated to...Boston Scientific CorporationEnrolling by invitationAcute Deep Venous Thrombosis of Femoral Vein (Disorder)China
-
Assiut UniversityNot yet recruitingRecurrent Varicose Vein of Lower Limb (Disorder)
-
UPECLIN HC FM Botucatu UnespCompletedProphylaxis of Deep Vein ThrombosisBrazil
-
MinaPharm PharmaceuticalsRecruitingProphylaxis of Deep Vein ThrombosisEgypt
-
Fudan UniversityCompletedthe Filling of Jugular Vein Before Anesthesia With and Without Valsalva ManeuverChina
-
Emory UniversityMaquet CardiovascularCompletedEndothelial Function of Saphenous Vein GraftsUnited States
Clinical Trials on Conventional Venepuncture
-
Monash UniversityUniversity of Melbourne; Wake Forest University; Invitae Corporation; Eastern Health and other collaboratorsRecruitingNeurodegenerative Diseases | DementiaAustralia
-
Maastricht University Medical CenterRecruitingPregnancy | Pre-Eclampsia | Intrauterine Growth Restriction | HELLP SyndromeNetherlands
-
Northern Care Alliance NHS Foundation TrustActive, not recruitingMyositisUnited Kingdom
-
LumiraDx UK LimitedCompleted
-
LumiraDx UK LimitedCompletedInfections | Inflammation | Tissue InjuryUnited Kingdom
-
Palacky UniversityUniversity of PardubiceCompleted
-
The Christie NHS Foundation TrustUniversity of ManchesterRecruiting
-
University of OxfordActive, not recruitingRespiratory Syncytial Virus Infections | RSV InfectionUnited Kingdom
-
Rajavithi HospitalUnknownTo Study Immunostatus of HIV-cancer Patients Who Recived RT Befor RT and Last Week of RT | To Study HIV Viral Load of HIV-cancer Patients Who Recived RT Befor RT and Last Week of RTThailand
-
Public Health EnglandUnknownLatent Tuberculosis | Active TuberculosisUnited Kingdom